Patent: 10,092,706
✉ Email this page to a colleague
Summary for Patent: 10,092,706
| Title: | Autoinjector apparatus |
| Abstract: | An autoinjector apparatus is disclosed which comprises a single-use cassette and an autoinjector. The cassette comprises a housing and a sleeve movably disposed in the housing. A syringe may be disposed in the sleeve and secured therein with a lock cap. The lock cap is affixed to a distal end of the sleeve and contacts the distal end of the syringe. A shield remover extends through an opening in a proximal end of the housing for removing a needle shield which covers a needle of the syringe. A cassette identification arrangement is provided on a surface of the housing to enable the autoinjector to identify the cassette. The autoinjector is provided with a detector for reading the cassette identification arrangement. |
| Inventor(s): | Denzer; Michael (Ringoes, NJ), Swift; Robert W. (Fillmore, CA), Johnston; Neal D. (Dallas, TX), Ganzitti; Gabriele (Milan, IT), Ewing; Kenneth R. (Fremont, CA), Krishna; Suhas (Simi Valley, CA) |
| Assignee: | AMGEN INC. (Thousand Oaks, CA) |
| Application Number: | 14/112,479 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,092,706
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2031-04-20 |
| Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2031-04-20 |
| Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2031-04-20 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
